[COVID-19 and cardiovascular and kidney disease: Where are we? Where are we going?]
Identifieur interne : 000024 ( Main/Exploration ); précédent : 000023; suivant : 000025[COVID-19 and cardiovascular and kidney disease: Where are we? Where are we going?]
Auteurs : V. Pallarés Carratalá [Espagne] ; C. G Rriz-Zambrano [Espagne] ; C. Morillas Ari O [Espagne] ; J L Llisterri Caro [Espagne] ; J L Gorriz [Espagne]Source :
- Semergen [ 1578-8865 ] ; 2020.
Abstract
The SARS-CoV-2 pandemic is a global health emergency and we need to know more about it. Patients with cardiovascular risk and previous kidney risk have been identified as especially vulnerable for greater morbidity and mortality when they suffer from COVID-19. A considerable proportion of patients can develop a vascular lesion in the context of the disease that entails a greater lethality. Cardiovascular and renal complications represent a problem and, probably in the near future, may pose a threat to patients who have survived COVID-19. As physicians, we cannot forget that during an epidemic like this, other chronic diseases are present, and patients continue to require care. We are obliged to monitor even more intensely their treatments and control degree. Furthermore, we must not forget that urgent situations continue to arise in this pandemic situation and require prompt attention. In this current situation, it is very likely that many patients, out of fear, have not sought medical attention. The situation during the epidemic and the uncertainty of the post-COVID-19 period, requires intensification in the control and monitoring of cardiovascular and kidney disease in our patients. Primary care constitutes a key level of care for the care of the population with cardiovascular disease. Likewise, and in the face of this new health scenario, we need to promote the prevention and control measures that emanate from the studies currently underway. Now, more than ever, we need research, crucial to improve the cardiovascular and renal prognosis of our patients.
DOI: 10.1016/j.semerg.2020.05.005
PubMed: 32448633
PubMed Central: PMC7211659
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[COVID-19 and cardiovascular and kidney disease: Where are we? Where are we going?]</title><author><name sortKey="Pallares Carratala, V" sort="Pallares Carratala, V" uniqKey="Pallares Carratala V" first="V" last="Pallarés Carratalá">V. Pallarés Carratalá</name><affiliation wicri:level="1"><nlm:affiliation>Medicina Familiar y Comunitaria, Unidad de Vigilancia de la Salud, Unión de Mutuas, Castellón, España; Departamento de Medicina, Facultad de Ciencias de la Salud, Universitat JaumeI, Castellón, España. Electronic address: pallares.vic@gmail.com.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Medicina Familiar y Comunitaria, Unidad de Vigilancia de la Salud, Unión de Mutuas, Castellón, España; Departamento de Medicina, Facultad de Ciencias de la Salud, Universitat JaumeI, Castellón</wicri:regionArea><wicri:noRegion>Castellón</wicri:noRegion></affiliation></author><author><name sortKey="G Rriz Zambrano, C" sort="G Rriz Zambrano, C" uniqKey="G Rriz Zambrano C" first="C" last="G Rriz-Zambrano">C. G Rriz-Zambrano</name><affiliation wicri:level="1"><nlm:affiliation>Medicina Familiar y Comunitaria, CAP Sant Pere, ABS Reus1, Reus, Tarragona, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Medicina Familiar y Comunitaria, CAP Sant Pere, ABS Reus1, Reus, Tarragona</wicri:regionArea><wicri:noRegion>Tarragona</wicri:noRegion></affiliation></author><author><name sortKey="Morillas Ari O, C" sort="Morillas Ari O, C" uniqKey="Morillas Ari O C" first="C" last="Morillas Ari O">C. Morillas Ari O</name><affiliation wicri:level="1"><nlm:affiliation>Servicio de Endocrinología, Hospital Universitario Dr. Peset, Valencia, España; Departamento de Medicina, Facultad de Medicina, Universitat de València, Valencia, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Servicio de Endocrinología, Hospital Universitario Dr. Peset, Valencia, España; Departamento de Medicina, Facultad de Medicina, Universitat de València, Valencia</wicri:regionArea><wicri:noRegion>Valencia</wicri:noRegion></affiliation></author><author><name sortKey="Llisterri Caro, J L" sort="Llisterri Caro, J L" uniqKey="Llisterri Caro J" first="J L" last="Llisterri Caro">J L Llisterri Caro</name><affiliation wicri:level="1"><nlm:affiliation>Medicina Familiar y Comunitaria, Fundación de Investigación SEMERGEN (Madrid), Clínica Vallada, Valencia, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Medicina Familiar y Comunitaria, Fundación de Investigación SEMERGEN (Madrid), Clínica Vallada, Valencia</wicri:regionArea><wicri:noRegion>Valencia</wicri:noRegion></affiliation></author><author><name sortKey="Gorriz, J L" sort="Gorriz, J L" uniqKey="Gorriz J" first="J L" last="Gorriz">J L Gorriz</name><affiliation wicri:level="1"><nlm:affiliation>Departamento de Medicina, Facultad de Medicina, Universitat de València, Valencia, España; Servicio de Nefrología, Hospital Clínico Universitario de Valencia, INCLIVA, Valencia, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Departamento de Medicina, Facultad de Medicina, Universitat de València, Valencia, España; Servicio de Nefrología, Hospital Clínico Universitario de Valencia, INCLIVA, Valencia</wicri:regionArea><wicri:noRegion>Valencia</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32448633</idno><idno type="pmid">32448633</idno><idno type="doi">10.1016/j.semerg.2020.05.005</idno><idno type="pmc">PMC7211659</idno><idno type="wicri:Area/Main/Corpus">000227</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000227</idno><idno type="wicri:Area/Main/Curation">000227</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000227</idno><idno type="wicri:Area/Main/Exploration">000227</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[COVID-19 and cardiovascular and kidney disease: Where are we? Where are we going?]</title><author><name sortKey="Pallares Carratala, V" sort="Pallares Carratala, V" uniqKey="Pallares Carratala V" first="V" last="Pallarés Carratalá">V. Pallarés Carratalá</name><affiliation wicri:level="1"><nlm:affiliation>Medicina Familiar y Comunitaria, Unidad de Vigilancia de la Salud, Unión de Mutuas, Castellón, España; Departamento de Medicina, Facultad de Ciencias de la Salud, Universitat JaumeI, Castellón, España. Electronic address: pallares.vic@gmail.com.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Medicina Familiar y Comunitaria, Unidad de Vigilancia de la Salud, Unión de Mutuas, Castellón, España; Departamento de Medicina, Facultad de Ciencias de la Salud, Universitat JaumeI, Castellón</wicri:regionArea><wicri:noRegion>Castellón</wicri:noRegion></affiliation></author><author><name sortKey="G Rriz Zambrano, C" sort="G Rriz Zambrano, C" uniqKey="G Rriz Zambrano C" first="C" last="G Rriz-Zambrano">C. G Rriz-Zambrano</name><affiliation wicri:level="1"><nlm:affiliation>Medicina Familiar y Comunitaria, CAP Sant Pere, ABS Reus1, Reus, Tarragona, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Medicina Familiar y Comunitaria, CAP Sant Pere, ABS Reus1, Reus, Tarragona</wicri:regionArea><wicri:noRegion>Tarragona</wicri:noRegion></affiliation></author><author><name sortKey="Morillas Ari O, C" sort="Morillas Ari O, C" uniqKey="Morillas Ari O C" first="C" last="Morillas Ari O">C. Morillas Ari O</name><affiliation wicri:level="1"><nlm:affiliation>Servicio de Endocrinología, Hospital Universitario Dr. Peset, Valencia, España; Departamento de Medicina, Facultad de Medicina, Universitat de València, Valencia, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Servicio de Endocrinología, Hospital Universitario Dr. Peset, Valencia, España; Departamento de Medicina, Facultad de Medicina, Universitat de València, Valencia</wicri:regionArea><wicri:noRegion>Valencia</wicri:noRegion></affiliation></author><author><name sortKey="Llisterri Caro, J L" sort="Llisterri Caro, J L" uniqKey="Llisterri Caro J" first="J L" last="Llisterri Caro">J L Llisterri Caro</name><affiliation wicri:level="1"><nlm:affiliation>Medicina Familiar y Comunitaria, Fundación de Investigación SEMERGEN (Madrid), Clínica Vallada, Valencia, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Medicina Familiar y Comunitaria, Fundación de Investigación SEMERGEN (Madrid), Clínica Vallada, Valencia</wicri:regionArea><wicri:noRegion>Valencia</wicri:noRegion></affiliation></author><author><name sortKey="Gorriz, J L" sort="Gorriz, J L" uniqKey="Gorriz J" first="J L" last="Gorriz">J L Gorriz</name><affiliation wicri:level="1"><nlm:affiliation>Departamento de Medicina, Facultad de Medicina, Universitat de València, Valencia, España; Servicio de Nefrología, Hospital Clínico Universitario de Valencia, INCLIVA, Valencia, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Departamento de Medicina, Facultad de Medicina, Universitat de València, Valencia, España; Servicio de Nefrología, Hospital Clínico Universitario de Valencia, INCLIVA, Valencia</wicri:regionArea><wicri:noRegion>Valencia</wicri:noRegion></affiliation></author></analytic><series><title level="j">Semergen</title><idno type="eISSN">1578-8865</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The SARS-CoV-2 pandemic is a global health emergency and we need to know more about it. Patients with cardiovascular risk and previous kidney risk have been identified as especially vulnerable for greater morbidity and mortality when they suffer from COVID-19. A considerable proportion of patients can develop a vascular lesion in the context of the disease that entails a greater lethality. Cardiovascular and renal complications represent a problem and, probably in the near future, may pose a threat to patients who have survived COVID-19. As physicians, we cannot forget that during an epidemic like this, other chronic diseases are present, and patients continue to require care. We are obliged to monitor even more intensely their treatments and control degree. Furthermore, we must not forget that urgent situations continue to arise in this pandemic situation and require prompt attention. In this current situation, it is very likely that many patients, out of fear, have not sought medical attention. The situation during the epidemic and the uncertainty of the post-COVID-19 period, requires intensification in the control and monitoring of cardiovascular and kidney disease in our patients. Primary care constitutes a key level of care for the care of the population with cardiovascular disease. Likewise, and in the face of this new health scenario, we need to promote the prevention and control measures that emanate from the studies currently underway. Now, more than ever, we need research, crucial to improve the cardiovascular and renal prognosis of our patients.</div></front></TEI><pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">32448633</PMID><DateRevised><Year>2020</Year><Month>06</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1578-8865</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2020</Year><Month>May</Month><Day>11</Day></PubDate></JournalIssue><Title>Semergen</Title><ISOAbbreviation>Semergen</ISOAbbreviation></Journal><ArticleTitle>[COVID-19 and cardiovascular and kidney disease: Where are we? Where are we going?]</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">S1138-3593(20)30144-1</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.semerg.2020.05.005</ELocationID><Abstract><AbstractText>The SARS-CoV-2 pandemic is a global health emergency and we need to know more about it. Patients with cardiovascular risk and previous kidney risk have been identified as especially vulnerable for greater morbidity and mortality when they suffer from COVID-19. A considerable proportion of patients can develop a vascular lesion in the context of the disease that entails a greater lethality. Cardiovascular and renal complications represent a problem and, probably in the near future, may pose a threat to patients who have survived COVID-19. As physicians, we cannot forget that during an epidemic like this, other chronic diseases are present, and patients continue to require care. We are obliged to monitor even more intensely their treatments and control degree. Furthermore, we must not forget that urgent situations continue to arise in this pandemic situation and require prompt attention. In this current situation, it is very likely that many patients, out of fear, have not sought medical attention. The situation during the epidemic and the uncertainty of the post-COVID-19 period, requires intensification in the control and monitoring of cardiovascular and kidney disease in our patients. Primary care constitutes a key level of care for the care of the population with cardiovascular disease. Likewise, and in the face of this new health scenario, we need to promote the prevention and control measures that emanate from the studies currently underway. Now, more than ever, we need research, crucial to improve the cardiovascular and renal prognosis of our patients.</AbstractText><CopyrightInformation>Copyright © 2020 Sociedad Española de Médicos de Atención Primaria (SEMERGEN). Publicado por Elsevier España, S.L.U. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pallarés Carratalá</LastName><ForeName>V</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Medicina Familiar y Comunitaria, Unidad de Vigilancia de la Salud, Unión de Mutuas, Castellón, España; Departamento de Medicina, Facultad de Ciencias de la Salud, Universitat JaumeI, Castellón, España. Electronic address: pallares.vic@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Górriz-Zambrano</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Medicina Familiar y Comunitaria, CAP Sant Pere, ABS Reus1, Reus, Tarragona, España.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morillas Ariño</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Servicio de Endocrinología, Hospital Universitario Dr. Peset, Valencia, España; Departamento de Medicina, Facultad de Medicina, Universitat de València, Valencia, España.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Llisterri Caro</LastName><ForeName>J L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Medicina Familiar y Comunitaria, Fundación de Investigación SEMERGEN (Madrid), Clínica Vallada, Valencia, España.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gorriz</LastName><ForeName>J L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Departamento de Medicina, Facultad de Medicina, Universitat de València, Valencia, España; Servicio de Nefrología, Hospital Clínico Universitario de Valencia, INCLIVA, Valencia, España.</Affiliation></AffiliationInfo></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><VernacularTitle>COVID-19 y enfermedad cardiovascular y renal: ¿Dónde estamos? ¿Hacia dónde vamos?</VernacularTitle><ArticleDate DateType="Electronic"><Year>2020</Year><Month>05</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Semergen</MedlineTA><NlmUniqueID>9610769</NlmUniqueID><ISSNLinking>1138-3593</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Cardiovascular disease</Keyword><Keyword MajorTopicYN="N">Chronic kidney disease</Keyword><Keyword MajorTopicYN="N">Enfermedad cardiovascular</Keyword><Keyword MajorTopicYN="N">Enfermedad renal crónica</Keyword><Keyword MajorTopicYN="N">Morbidity</Keyword><Keyword MajorTopicYN="N">Morbilidad</Keyword><Keyword MajorTopicYN="N">Mortalidad</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>05</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>05</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>5</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>5</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>5</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32448633</ArticleId><ArticleId IdType="pii">S1138-3593(20)30144-1</ArticleId><ArticleId IdType="doi">10.1016/j.semerg.2020.05.005</ArticleId><ArticleId IdType="pmc">PMC7211659</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zhonghua Jie He He Hu Xi Za Zhi. 2020 Mar 12;43(3):219-222</Citation><ArticleIdList><ArticleId IdType="pubmed">32164092</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2016 Nov 3;375(18):1801-2</Citation><ArticleIdList><ArticleId IdType="pubmed">27806236</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2020 May 2;395(10234):1417-1418</Citation><ArticleIdList><ArticleId IdType="pubmed">32325026</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2017 Aug 17;377(7):644-657</Citation><ArticleIdList><ArticleId IdType="pubmed">28605608</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Int. 2020 May;97(5):829-838</Citation><ArticleIdList><ArticleId IdType="pubmed">32247631</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2014 Sep 11;371(11):993-1004</Citation><ArticleIdList><ArticleId IdType="pubmed">25176015</ArticleId></ArticleIdList></Reference><Reference><Citation>Semergen. 2019 Jul - Aug;45(5):333-348</Citation><ArticleIdList><ArticleId IdType="pubmed">31164311</ArticleId></ArticleIdList></Reference><Reference><Citation>Semergen. 2020 Apr;46(3):149-150</Citation><ArticleIdList><ArticleId IdType="pubmed">32234284</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2020 Apr 23;382(17):1653-1659</Citation><ArticleIdList><ArticleId IdType="pubmed">32227760</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Soc Hypertens. 2014 May;8(5):330-9</Citation><ArticleIdList><ArticleId IdType="pubmed">24631482</ArticleId></ArticleIdList></Reference><Reference><Citation>Semergen. 2016 Oct;42(7):464-475</Citation><ArticleIdList><ArticleId IdType="pubmed">27641310</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Res Cardiol. 2020 May;109(5):531-538</Citation><ArticleIdList><ArticleId IdType="pubmed">32161990</ArticleId></ArticleIdList></Reference><Reference><Citation>Hypertension. 2014 Dec;64(6):1368-1375</Citation><ArticleIdList><ArticleId IdType="pubmed">25225202</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Infect Dis. 2020 Apr;20(4):411-412</Citation><ArticleIdList><ArticleId IdType="pubmed">32105638</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Infect Dis. 2020 May;20(5):e102-e107</Citation><ArticleIdList><ArticleId IdType="pubmed">32145768</ArticleId></ArticleIdList></Reference><Reference><Citation>Semergen. 2019 Sep;45(6):366-374</Citation><ArticleIdList><ArticleId IdType="pubmed">30541706</ArticleId></ArticleIdList></Reference><Reference><Citation>Resuscitation. 2012 Dec;83(12):1427-33</Citation><ArticleIdList><ArticleId IdType="pubmed">22960567</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2015 Nov 26;373(22):2117-28</Citation><ArticleIdList><ArticleId IdType="pubmed">26378978</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Hypertens Rep. 2012 Apr;14(2):170-6</Citation><ArticleIdList><ArticleId IdType="pubmed">22258314</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2019 Aug 27;140(9):739-750</Citation><ArticleIdList><ArticleId IdType="pubmed">31291786</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2020 Feb 15;395(10223):497-506</Citation><ArticleIdList><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Ther. 2016 Dec;38(12):2654-2664.e1</Citation><ArticleIdList><ArticleId IdType="pubmed">28003053</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2016 Jul 28;375(4):311-22</Citation><ArticleIdList><ArticleId IdType="pubmed">27295427</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2005 May 24;111(20):2605-10</Citation><ArticleIdList><ArticleId IdType="pubmed">15897343</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2019 Nov 21;381(21):1995-2008</Citation><ArticleIdList><ArticleId IdType="pubmed">31535829</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Soc Hypertens. 2014 Apr;8(4):262-75.e9</Citation><ArticleIdList><ArticleId IdType="pubmed">24602971</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2020 Feb 15;395(10223):507-513</Citation><ArticleIdList><ArticleId IdType="pubmed">32007143</ArticleId></ArticleIdList></Reference><Reference><Citation>Enferm Infecc Microbiol Clin. 2015 Aug-Sep;33(7):e15-30</Citation><ArticleIdList><ArticleId IdType="pubmed">24913990</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Cardiol. 2020 May;17(5):259-260</Citation><ArticleIdList><ArticleId IdType="pubmed">32139904</ArticleId></ArticleIdList></Reference><Reference><Citation>Rev Esp Cardiol (Engl Ed). 2020 Feb;73(2):161-167</Citation><ArticleIdList><ArticleId IdType="pubmed">31818706</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Espagne</li></country></list><tree><country name="Espagne"><noRegion><name sortKey="Pallares Carratala, V" sort="Pallares Carratala, V" uniqKey="Pallares Carratala V" first="V" last="Pallarés Carratalá">V. Pallarés Carratalá</name></noRegion><name sortKey="G Rriz Zambrano, C" sort="G Rriz Zambrano, C" uniqKey="G Rriz Zambrano C" first="C" last="G Rriz-Zambrano">C. G Rriz-Zambrano</name><name sortKey="Gorriz, J L" sort="Gorriz, J L" uniqKey="Gorriz J" first="J L" last="Gorriz">J L Gorriz</name><name sortKey="Llisterri Caro, J L" sort="Llisterri Caro, J L" uniqKey="Llisterri Caro J" first="J L" last="Llisterri Caro">J L Llisterri Caro</name><name sortKey="Morillas Ari O, C" sort="Morillas Ari O, C" uniqKey="Morillas Ari O C" first="C" last="Morillas Ari O">C. Morillas Ari O</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CardioCovidV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000024 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000024 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CardioCovidV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32448633
|texte= [COVID-19 and cardiovascular and kidney disease: Where are we? Where are we going?]
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32448633" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a CardioCovidV1
| This area was generated with Dilib version V0.6.35. |  |